{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T02:30:33Z","timestamp":1770690633107,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T00:00:00Z","timestamp":1631750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL113056"],"award-info":[{"award-number":["R01-HL113056"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C"],"award-info":[{"award-number":["HHSN268201600018C, HHSN268201600001C, HHSN268201600002C, HHSN268201600003C, HHSN268201600004C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006733","name":"Indiana University","doi-asserted-by":"publisher","award":["Indiana University Health-Indiana University School of Medicine Strategic Research Initiative Grant"],"award-info":[{"award-number":["Indiana University Health-Indiana University School of Medicine Strategic Research Initiative Grant"]}],"id":[{"id":"10.13039\/100006733","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background\/objectives<\/jats:title>\n                <jats:p>There is evidence of black\u2013white differences in vitamin D status and cardiometabolic health. This study aimed to further evaluate the joint associations of 25-hydroxyvitamin D [25(OH)D] and parathyroid hormone (PTH) with risks of diabetes and related cardiometabolic comorbidities among white and black women.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Subjects\/methods<\/jats:title>\n                <jats:p>We cross-sectionally and prospectively analyzed data from 1850 black and 3000 white postmenopausal women without cardiovascular disease or dialysis at baseline from the Women\u2019s Health Initiative\u2014Observational Study. Weighted Cox proportional hazards analyses and weighted logistic regression models were used to examine the joint associations of 25(OH)D and PTH with incident diabetes and prevalence of other diabetes-related cardiometabolic comorbidities (including CKD, hypertension, or obesity).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 3322 cases of obesity (<jats:italic>n<\/jats:italic>\u2009=\u20091629), hypertension (<jats:italic>n<\/jats:italic>\u2009=\u20092759), or CKD (<jats:italic>n<\/jats:italic>\u2009=\u2009318) at baseline and 453 incident cases of diabetes during 11 years of follow-up. Cross-sectionally, lower 25(OH)D and higher PTH were independently associated with higher prevalence of hypertension [odds ratio (OR)\u2009=\u20090.79; 95% confidence interval (CI): 0.72\u20130.87 and OR\u2009=\u20091.55; 95% CI: 1.39\u20131.73] among white women only. When stratified by diabetes status, compared to women with 25(OH)D \u226550\u2009nmol\/L and PTH \u22646.89\u2009pmol\/L (65\u2009pg\/mL), women who did not have diabetes with vitamin D deficiency (&lt;50\u2009nmol\/L) and PTH excess (&gt;6.89\u2009pmol\/L) had higher prevalence of CKD, hypertension, or obesity (OR\u2009=\u20094.23; 95% CI: 2.90\u20136.18) than women who had diabetes (OR\u2009=\u20091.89; 95% CI: 0.96\u20133.71). Prospectively, lower 25(OH)D was associated with lower diabetes incidence [hazard ratio (HR)\u2009=\u20090.73; 95% CI: 0.62\u20130.86] in white women. Jointly, compared to the group with 25(OH)D \u226550\u2009nmol\/L and PTH \u22646.89\u2009pmol\/L, white women with 25(OH)D deficiency (&lt;50\u2009nmol\/L) had elevated risk for diabetes, regardless of PTH levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Low 25(OH)D and high PTH were jointly associated with increased risk of diabetes among white women only. Their joint associations with high prevalence of CKD, hypertension, and obesity were more pronounced among women without diabetes.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41387-021-00171-2","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T11:03:54Z","timestamp":1631790234000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Combined associations of 25-hydroxivitamin D and parathyroid hormone with diabetes risk and associated comorbidities among U.S. white and black women"],"prefix":"10.1038","volume":"11","author":[{"given":"Jin","family":"Xia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanzhu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn E.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmei","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aladdin H.","family":"Shadyab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer W.","family":"Bea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily W.","family":"Gower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Yuan David","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-7332","authenticated-orcid":false,"given":"Yiqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"171_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1017\/S1368980014000457","volume":"18","author":"GB Taksler","year":"2015","unstructured":"Taksler GB, Cutler DM, Giovannucci E, Keating NL. Vitamin D deficiency in minority populations. Public Health Nutr. 2015;18:379\u201391.","journal-title":"Public Health Nutr"},{"key":"171_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(82)90214-8","volume":"1","author":"TL Clemens","year":"1982","unstructured":"Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982;1:74\u20136.","journal-title":"Lancet"},{"key":"171_CR3","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139:e56\u2013e528.","journal-title":"Circulation"},{"key":"171_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1172\/JCI0215219","volume":"110","author":"YC Li","year":"2002","unstructured":"Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002;110:419\u201346.","journal-title":"J Clin Invest."},{"key":"171_CR5","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1152\/ajprenal.00336.2004","volume":"289","author":"AS Dusso","year":"2005","unstructured":"Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Ren Physiol. 2005;289:F8\u201328.","journal-title":"Am J Physiol Ren Physiol."},{"key":"171_CR6","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1210\/en.2010-0089","volume":"151","author":"V Lagishetty","year":"2010","unstructured":"Lagishetty V, Misharin AV, Liu NQ, Lisse TS, Chun RF, Ouyang Y, et al. Vitamin D deficiency in mice impairs colonic antibacterial activity and predisposes to colitis. Endocrinology. 2010;151:2423\u201332.","journal-title":"Endocrinology"},{"key":"171_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/HYPERTENSIONAHA.114.03971","volume":"64","author":"W Ni","year":"2014","unstructured":"Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Elimination of vitamin D receptor in vascular endothelial cells alters vascular function. Hypertension. 2014;64:229\u201338.","journal-title":"Hypertension"},{"key":"171_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1056\/NEJMoa1900906","volume":"381","author":"AG Pittas","year":"2019","unstructured":"Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381:520\u201330.","journal-title":"N Engl J Med."},{"key":"171_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1530\/EJE-19-0156","volume":"181","author":"P Lemieux","year":"2019","unstructured":"Lemieux P, Weisnagel SJ, Caron AZ, Julien AS, Morisset AS, Carreau AM, et al. Effects of 6-month vitamin D supplementation on insulin sensitivity and secretion: a randomized, placebo-controlled trial. Eur J Endocrinol. 2019;181:287\u201399.","journal-title":"Eur J Endocrinol"},{"key":"171_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.nutres.2015.02.001","volume":"35","author":"L Gonz\u00e1lez","year":"2015","unstructured":"Gonz\u00e1lez L, Ramos-Trautmann G, D\u00edaz-Luquis GM, P\u00e9rez CM, Palacios C. Vitamin D status is inversely associated with obesity in a clinic-based sample in Puerto Rico. Nutr Res. 2015;35:287\u201393.","journal-title":"Nutr Res."},{"key":"171_CR11","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/HYPERTENSIONAHA.108.117630","volume":"52","author":"JP Forman","year":"2008","unstructured":"Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52:828\u201332.","journal-title":"Hypertension"},{"key":"171_CR12","first-page":"8","volume":"19","author":"S Williams","year":"2009","unstructured":"Williams S, Malatesta K, Norris K. Vitamin D and chronic kidney disease. Ethn Dis. 2009;19:8\u201311.","journal-title":"Ethn Dis."},{"key":"171_CR13","doi-asserted-by":"publisher","first-page":"331.3","DOI":"10.1016\/j.ahj.2011.05.005","volume":"162","author":"JL Anderson","year":"2011","unstructured":"Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lapp\u00e9 DL, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J. 2011;162:331.3.e2.","journal-title":"Am Heart J."},{"key":"171_CR14","doi-asserted-by":"crossref","first-page":"e011021","DOI":"10.1161\/JAHA.118.011021","volume":"8","author":"X Zhang","year":"2019","unstructured":"Zhang X, Tu W, Manson JE, Tinker L, Liu S, Cauley JA, et al. Racial\/ethnic differences in 25-hydroxy vitamin D and parathyroid hormone levels and cardiovascular disease risk among postmenopausal women. J Am Heart Assoc. 2019;8:e011021.","journal-title":"J Am Heart Assoc."},{"key":"171_CR15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1177\/1740774508091749","volume":"5","author":"KL Margolis","year":"2008","unstructured":"Margolis KL, Lihong QI, Brzyski R, Bonds DE, Howard BV, Kempainen S, et al. Validity of diabetes self-reports in the Women\u2019s Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials. 2008;5:240\u20137.","journal-title":"Clin Trials."},{"key":"171_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med."},{"key":"171_CR17","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/S0895-4356(99)00102-X","volume":"52","author":"WE Barlow","year":"1999","unstructured":"Barlow WE, Ichikawa L, Rosner D, Izumi S. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52:1165\u201372.","journal-title":"J Clin Epidemiol"},{"key":"171_CR18","doi-asserted-by":"publisher","first-page":"e0193070","DOI":"10.1371\/journal.pone.0193070","volume":"13","author":"SK Park","year":"2018","unstructured":"Park SK, Garland CF, Gorham ED, BuDoff L, Barrett-Connor E. Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study. PLoS ONE. 2018;13:e0193070.","journal-title":"PLoS ONE"},{"key":"171_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10654-013-9769-z","volume":"28","author":"B Sch\u00f6ttker","year":"2013","unstructured":"Sch\u00f6ttker B, Herder C, Rothenbacher D, Perna L, M\u00fcller H, Brenner H. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol. 2013;28:267\u201375.","journal-title":"Eur J Epidemiol."},{"key":"171_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2337\/dc12-0962","volume":"36","author":"Y Song","year":"2013","unstructured":"Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013;36:1422\u20138.","journal-title":"Diabetes Care"},{"key":"171_CR21","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.2337\/db14-0489","volume":"63","author":"CK Kramer","year":"2014","unstructured":"Kramer CK, Swaminathan B, Hanley AJ, Connelly PW, Sermer M, Zinman B, et al. Prospective associations of vitamin D status with \u03b2-cell function, insulin sensitivity, and glycemia: the impact of parathyroid hormone status. Diabetes. 2014;63:3868\u201379.","journal-title":"Diabetes"},{"key":"171_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1177\/1479164117738443","volume":"15","author":"SN Karras","year":"2018","unstructured":"Karras SN, Anagnostis P, Antonopoulou V, Tsekmekidou X, Koufakis T, Goulis DG, et al. The combined effect of vitamin D and prarthyroid hormone concentrations on glucose homeostasis in older patients with prediabetes: a cross-sectional study. Diab Vasc Dis Res. 2018;15:150\u20133.","journal-title":"Diab Vasc Dis Res."},{"key":"171_CR23","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1210\/jc.2013-3883","volume":"99","author":"N Veronese","year":"2014","unstructured":"Veronese N, Sergi G, De Rui M, Bolzetta F, Toffanello ED, Zambon S, et al. Serum 25-hydroxyvitamin D and incidence of diabetes in elderly people: the PRO.V.A. study. J Clin Endocrinol Metab. 2014;99:2351\u20138.","journal-title":"J Clin Endocrinol Metab."},{"key":"171_CR24","first-page":"7908764","volume":"2018","author":"H Tang","year":"2018","unstructured":"Tang H, Li D, Li Y, Zhang X, Song Y, Li X. Effects of vitamin D supplementation on glucose and insulin homeostasis and incident diabetes among nondiabetic adults: a meta-analysis of randomized controlled trials. Int J Endocrinol. 2018;2018:7908764.","journal-title":"Int J Endocrinol."},{"key":"171_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/ajcn\/87.1.136","volume":"87","author":"SE Judd","year":"2008","unstructured":"Judd SE, Nanes MS, Xiegler TR, Wilson PW, Tangpricha V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2008;87:136\u201341.","journal-title":"Am J Clin Nutr."},{"key":"171_CR26","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/j.1365-2796.2007.01778.x","volume":"261","author":"MB Snijder","year":"2007","unstructured":"Snijder MB, Lips P, Seidell JC, Visser M, Deeg DJ, Dekker JM, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007;261:558\u201365.","journal-title":"J Intern Med."},{"key":"171_CR27","first-page":"7435657","volume":"2017","author":"WH Wang","year":"2017","unstructured":"Wang WH, Chen LW, Lee CC, Sun CY, Shyu YC, Hsu HR, et al. Association between parathyroid hormone, 25(OH)vitamin D, and chronic kidney disease: a population-based study. Biomed Res Int. 2017;2017:7435657.","journal-title":"Biomed Res Int."},{"key":"171_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12882-019-1202-8","volume":"20","author":"M Liu","year":"2019","unstructured":"Liu M, Wang J, He Y. Serum 25-hydroxyvitamin D were associated with higher risk of both albuminuria and impaired GFR incidence: a cohort study based on CLHLS study. BMC Nephrol. 2019;20:20.","journal-title":"BMC Nephrol"},{"key":"171_CR29","doi-asserted-by":"publisher","first-page":"4119","DOI":"10.1210\/jc.2005-0216","volume":"90","author":"MB Snijder","year":"2015","unstructured":"Snijder MB, van Dam RM, Visser M, Deeg DJH, Dekker JM, Bouter LM, et al. Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab. 2015;90:4119\u201323.","journal-title":"J Clin Endocrinol Metab."},{"key":"171_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.bone.2005.08.018","volume":"38","author":"MJ Bolland","year":"2006","unstructured":"Bolland MJ, Grey AB, Ames RW, Horne AM, Gamble GD, Reid IR. Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone. 2006;38:317\u201321.","journal-title":"Bone"},{"key":"171_CR31","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1475-2840-11-149","volume":"11","author":"A Guasch","year":"2012","unstructured":"Guasch A, Bull\u00f3 M, Rabassa A, Bonada A, Del Castillo D, Sabench F, et al. Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study. Cardiovasc Diabetol. 2012;11:149.","journal-title":"Cardiovasc Diabetol."},{"key":"171_CR32","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","volume":"116","author":"L Te Riet","year":"2015","unstructured":"Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116:960\u201375.","journal-title":"Circ Res."},{"key":"171_CR33","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1159\/000313363","volume":"31","author":"HM Siragy","year":"2010","unstructured":"Siragy HM, Carey RM. Role of the intrarenal renin-angiotensin-aldosterone system in chronic kidney disease. Am J Nephrol. 2010;31:541\u201350.","journal-title":"Am J Nephrol."},{"key":"171_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1056\/NEJM198910263211703","volume":"321","author":"JH Pratt","year":"1989","unstructured":"Pratt JH, Jones JJ, Miller JZ, Wagner MA, Feineberg NS. Racial differences in aldosterone excretion and plasma aldosterone concentrations in children. N Engl J Med. 1989;321:1152\u20137.","journal-title":"N Engl J Med"},{"key":"171_CR35","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.109.148619","volume":"55","author":"JP Forman","year":"2010","unstructured":"Forman JP, Williams JS, Fisher ND. Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans. Hypertension. 2010;55:1283\u20138.","journal-title":"Hypertension"},{"key":"171_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/cvr\/cvs092","volume":"94","author":"A Tomaschitz","year":"2012","unstructured":"Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res. 2012;94:10\u20139.","journal-title":"Cardiovasc Res."},{"key":"171_CR37","doi-asserted-by":"crossref","unstructured":"Zemel MB, Sun XC. Vitamin D modulation of adipocyte function. In: Holick M, editor. Vitamin D. Nutrition and health. Totowa, NJ: Humana Press; 2010. p. 345\u201358.","DOI":"10.1007\/978-1-60327-303-9_17"},{"key":"171_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0306-9877(03)00227-5","volume":"61","author":"MF McCarty","year":"2003","unstructured":"McCarty MF, Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses. 2003;61:535\u201342.","journal-title":"Med Hypotheses"},{"key":"171_CR39","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.4049\/jimmunol.1102412","volume":"188","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, et al. Vitamin D inhibits monocyte\/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188:2127\u201335.","journal-title":"J Immunol."},{"key":"171_CR40","doi-asserted-by":"publisher","first-page":"F1215","DOI":"10.1152\/ajprenal.00406.2006","volume":"292","author":"G Rashid","year":"2007","unstructured":"Rashid G, Bernheim J, Green J, Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways. Am J Physiol Ren Physiol. 2007;292:F1215\u20138.","journal-title":"Am J Physiol Ren Physiol."},{"key":"171_CR41","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1161\/CIRCULATIONAHA.113.002654","volume":"128","author":"E Kassi","year":"2013","unstructured":"Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation. 2013;128:2517\u201331.","journal-title":"Circulation"},{"key":"171_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ajcn\/nqaa121","volume":"112","author":"J Xia","year":"2020","unstructured":"Xia J, Tu W, Manson JE, Nan H, Shadyab AH, Bea JW, et al. Race-specific associations of 25-hydroxyvitamin D and parathyroid hormone with cardiometabolic biomarkers among US white and black postmenopausal women. Am J Clin Nutr. 2020;112:257\u201367.","journal-title":"Am J Clin Nutr"}],"container-title":["Nutrition &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00171-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00171-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T14:19:12Z","timestamp":1669817952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-021-00171-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,16]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1038\/s41387-021-00171-2","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,16]]},"assertion":[{"value":"6 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.E.M. is a recipient of funding from the National Institutes of Health to conduct VITAL (Vitamin D and Omega-3 Trial), a large-scale randomized trial of vitamin D and omega-3s in the prevention of cancer and cardiovascular disease. The vitamin D study pills were donated by Pharmavite LLC (Northridge, CA). All other authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}